info@seedtherapeutics.com | 646-859-2751info@seedtherapeutics.com   |  646-859-2751 PRESS RELEASESSeed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer “Molecular Glue” Protein Degradation...